These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 6786600)

  • 1. Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.
    Miller NE; Hammett F; Saltissi S; Rao S; van Zeller H; Coltart J; Lewis B
    Br Med J (Clin Res Ed); 1981 May; 282(6278):1741-4. PubMed ID: 6786600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
    Kempen HJ; van Gent CM; Buytenhek R; Buis B
    J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction.
    Hamsten A; Walldius G; Szamosi A; Dahlen G; de Faire U
    Circulation; 1986 Jun; 73(6):1097-110. PubMed ID: 3698244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
    Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
    Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of lipoproteins and apolipoproteins with gradient gel electrophoresis estimates of high density lipoprotein subfractions in men and women.
    Williams PT; Krauss RM; Vranizan KM; Stefanick ML; Wood PD; Lindgren FT
    Arterioscler Thromb; 1992 Mar; 12(3):332-40. PubMed ID: 1547192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of plasma levels and composition of apolipoprotein B-containing lipoproteins to angiographically defined coronary artery disease in young patients with myocardial infarction.
    Tornvall P; Båvenholm P; Landou C; de Faire U; Hamsten A
    Circulation; 1993 Nov; 88(5 Pt 1):2180-9. PubMed ID: 8222113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation of angiographically defined coronary artery disease to serum lipoprotein levels.
    O'Sullivan JJ; Matthew A; Conroy RM; Erwin RJ; Duggan PF
    Clin Cardiol; 1990 Dec; 13(12):841-4. PubMed ID: 2282727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein and apolipoprotein levels in angiographically defined coronary atherosclerosis.
    Schmidt SB; Wasserman AG; Muesing RA; Schlesselman SE; Larosa JC; Ross AM
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1459-62. PubMed ID: 3923814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the cholesterol content and subfraction distribution of plasma high-density lipoproteins.
    Shepherd J; Packard CJ; Stewart JM; Vallance BD; Lawrie TD; Morgan HG
    Clin Chim Acta; 1980 Feb; 101(1):57-62. PubMed ID: 7357738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease.
    Noma A; Yokosuka T; Kitamura K
    Atherosclerosis; 1983 Oct; 49(1):1-7. PubMed ID: 6651909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma apolipoprotein B and VLDL-, LDL-, and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography.
    Whayne TF; Alaupovic P; Curry MD; Lee ET; Anderson PS; Schechter E
    Atherosclerosis; 1981 Jun; 39(3):411-24. PubMed ID: 6942843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease.
    Drexel H; Amann FW; Rentsch K; Neuenschwander C; Luethy A; Khan SI; Follath F
    Am J Cardiol; 1992 Aug; 70(4):436-40. PubMed ID: 1642180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I as a marker of angiographically assessed coronary-artery disease.
    Maciejko JJ; Holmes DR; Kottke BA; Zinsmeister AR; Dinh DM; Mao SJ
    N Engl J Med; 1983 Aug; 309(7):385-9. PubMed ID: 6410239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
    Phillips NR; Waters D; Havel RJ
    Circulation; 1993 Dec; 88(6):2762-70. PubMed ID: 8252689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipids and other lipids in angiographically assessed coronary artery disease.
    Bovet P; Darioli R; Essinger A; Golay A; Sigwart U; Kappenberger L
    Atherosclerosis; 1989 Nov; 80(1):41-7. PubMed ID: 2604756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
    Artery; 1983; 12(1):1-23. PubMed ID: 6431945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density-lipoprotein subfractions of patients using cardio-selective beta-blockers.
    Kuster GM; Amann FW; Neuenschwander C; Drexel H
    Cardiovasc Drugs Ther; 2002 Mar; 16(2):127-31. PubMed ID: 12090905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein subfractions, apolipoproteins and antipyrine clearance in normal subjects.
    Luoma PV; Rautio A; Stengård J; Sotaniemi EA; Marniemi J
    Eur J Clin Pharmacol; 1990; 38(6):625-7. PubMed ID: 2373138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT).
    Ruotolo G; Ericsson CG; Tettamanti C; Karpe F; Grip L; Svane B; Nilsson J; de Faire U; Hamsten A
    J Am Coll Cardiol; 1998 Nov; 32(6):1648-56. PubMed ID: 9822092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.